• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Pulmonary effects of furosemide in preterm infants with lung disease.

作者信息

Najak Z D, Harris E M, Lazzara A, Pruitt A W

出版信息

J Pediatr. 1983 May;102(5):758-63. doi: 10.1016/s0022-3476(83)80253-4.

DOI:10.1016/s0022-3476(83)80253-4
PMID:6842336
Abstract

Twenty preterm infants recovering from respiratory distress syndrome at 1 week of age were randomized in this study either to a control or a treatment group. Those treated received a single daily dose of furosemide (1 mg/kg) intravenously. Pulmonary compliance was observed to improve significantly at two hours in the treated group, as compared with that in the controls. The calculated alveolar-arterial oxygen gradient was noted to decrease two hours after furosemide and to remain decreased over the four-day period in the treated group. This improvement in lung function was not secondary to diuresis in the infants treated with furosemide. We conclude that furosemide may have a direct pulmonary effect and improve lung function acutely as well as with chronic administration.

摘要

相似文献

1
Pulmonary effects of furosemide in preterm infants with lung disease.
J Pediatr. 1983 May;102(5):758-63. doi: 10.1016/s0022-3476(83)80253-4.
2
Dose-dependent evaluation of the effects of nebulized furosemide on pulmonary function in ventilated preterm infants.雾化呋塞米对机械通气早产儿肺功能影响的剂量依赖性评估
J Perinatol. 1998 Sep-Oct;18(5):357-60.
3
Effect of early furosemide administration in neonates with respiratory distress syndrome.早期给予呋塞米对新生儿呼吸窘迫综合征的影响。
Pediatr Pulmonol. 1987 Jul-Aug;3(4):219-25. doi: 10.1002/ppul.1950030405.
4
Early furosemide therapy in premature infants (less than or equal to 2000 gm) with respiratory distress syndrome: a randomized controlled trial.早期使用速尿治疗小于或等于2000克的患有呼吸窘迫综合征的早产儿:一项随机对照试验。
J Pediatr. 1984 Oct;105(4):603-9. doi: 10.1016/s0022-3476(84)80431-x.
5
Prophylactic furosemide in severe respiratory distress syndrome: blinded prospective study.重度呼吸窘迫综合征预防性使用呋塞米:双盲前瞻性研究
J Pediatr. 1988 Apr;112(4):605-12. doi: 10.1016/s0022-3476(88)80182-3.
6
Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease.用于患有(或正在发展为)慢性肺病的早产儿的静脉或肠内袢利尿剂。
Cochrane Database Syst Rev. 2000(4):CD001453. doi: 10.1002/14651858.CD001453.
7
Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease.用于患有(或正在发展为)慢性肺病的早产儿的静脉或肠内袢利尿剂。
Cochrane Database Syst Rev. 2000(2):CD001453. doi: 10.1002/14651858.CD001453.
8
Diuresis and pulmonary function in premature infants with respiratory distress syndrome.呼吸窘迫综合征早产儿的利尿与肺功能
J Pediatr. 1983 Oct;103(4):618-23. doi: 10.1016/s0022-3476(83)80601-5.
9
Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease.用于患有(或正在发展为)慢性肺病的早产儿的静脉或肠内袢利尿剂。
Cochrane Database Syst Rev. 2002(1):CD001453. doi: 10.1002/14651858.CD001453.
10
Diuretics for respiratory distress syndrome in preterm infants.用于治疗早产儿呼吸窘迫综合征的利尿剂
Cochrane Database Syst Rev. 2001(2):CD001454. doi: 10.1002/14651858.CD001454.

引用本文的文献

1
Pharmacotherapy in Bronchopulmonary Dysplasia: What Is the Evidence?支气管肺发育不良的药物治疗:证据有哪些?
Front Pediatr. 2022 Mar 9;10:820259. doi: 10.3389/fped.2022.820259. eCollection 2022.
2
Optimizing respiratory management in preterm infants: a review of adjuvant pharmacotherapies.优化早产儿的呼吸管理:辅助药物治疗的综述。
J Perinatol. 2021 Oct;41(10):2395-2407. doi: 10.1038/s41372-021-01139-x. Epub 2021 Jul 9.
3
Bronchopulmonary Dysplasia: An Update of Current Pharmacologic Therapies and New Approaches.支气管肺发育不良:当前药物治疗及新方法的最新进展
Clin Med Insights Pediatr. 2018 Dec 11;12:1179556518817322. doi: 10.1177/1179556518817322. eCollection 2018.
4
Use of calcimimetics in children with normal kidney function.在肾功能正常的儿童中使用钙敏感受体激动剂。
Pediatr Nephrol. 2019 Mar;34(3):413-422. doi: 10.1007/s00467-018-3935-1. Epub 2018 Mar 19.
5
Updates on Functional Characterization of Bronchopulmonary Dysplasia - The Contribution of Lung Function Testing.支气管肺发育不良的功能特征更新——肺功能测试的贡献。
Front Med (Lausanne). 2015 May 29;2:35. doi: 10.3389/fmed.2015.00035. eCollection 2015.
6
Point Prevalence, Clinical Characteristics, and Treatment Variation for Infants with Severe Bronchopulmonary Dysplasia.重度支气管肺发育不良婴儿的现患率、临床特征及治疗差异
Am J Perinatol. 2015 Aug;32(10):960-7. doi: 10.1055/s-0035-1547326. Epub 2015 Mar 4.
7
Unexpected extra-renal effects of loop diuretics in the preterm neonate.利尿剂在早产儿中的意外肾脏外作用。
Acta Paediatr. 2012 Aug;101(8):835-45. doi: 10.1111/j.1651-2227.2012.02699.x. Epub 2012 May 28.
8
Nebulized furosemide in the treatment of bronchopulmonary dysplasia in preterm infants.雾化呋塞米治疗早产儿支气管肺发育不良
J Pediatr Pharmacol Ther. 2011 Jan;16(1):14-22.
9
Pharmacological closure of the patent ductus arteriosus.动脉导管未闭的药物性闭合
Images Paediatr Cardiol. 2003 Jan;5(1):1-15.
10
Current pharmacologic approaches for prevention and treatment of bronchopulmonary dysplasia.预防和治疗支气管肺发育不良的当前药理学方法。
Int J Pediatr. 2012;2012:598606. doi: 10.1155/2012/598606. Epub 2012 Jan 3.